Responses to captopril and hydrochlorothiazide in black patients with hypertension
- 1 September 1982
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 32 (3) , 307-312
- https://doi.org/10.1038/clpt.1982.165
Abstract
The effects of captopril (C) in doses of up to 450 mg/day, placebo (P) and hydrochlorothiazide (H) in doses of 50-100 mg/day were compared in double-blind studies in 38 black patients. Mean blood pressure response to C was only slightly greater than to P (systolic response difference only). Mean blood pressure responses to H were greater than to C. Results were compared to available data on 185 white and black patients treated similarly. In white patients, response to C was greater than to P, but response to H was approximately equal to that of C. In black patients, the systolic response to C was greater than that to P and the response to H was greater than that to C. Apparently, black and white patients differ in response to certain antihypertensive drugs.This publication has 5 references indexed in Scilit:
- Efficacy of an oral angiotensin-converting enzyme inhibitor (captopril) in severe hypertensionArchives of internal medicine (1960), 1981
- Captopril in severe treatment-resistant hypertensionAmerican Heart Journal, 1980
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MANThe Lancet, 1977